The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide pharmaceutical and medical supplies to military treatment facilities worldwide. The contract has a potential value of up to $5,999,999 and a period of performance through December 31, 2025.
Under this IDC, DMS Pharmaceutical Group will deliver a variety of pharmaceutical and medical products on a firm fixed-price basis, including flumazenil injection, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, selenium sulfide lotion, neomycin and polymyxin antibiotics, surgical detergent, artificial tears, testosterone gel, human albumin, contraceptive implants, atropine, Surgilube lubricant, heparin, Narcan nasal spray, intravenous saline, and midazolam hydrochloride. These supplies will be used to fulfill the routine needs of military treatment centers supported by the DLA worldwide.
Generated 4/10/24, 9:16 AM